ArticleBlood research2022

Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia.

Hye-Ji Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.